• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Transforming Healthcare & Pharma with Virtual and Augmented Reality

Article

On July 17, experts in VR & AR from Penn Medicine, Biogen, Stanford University and VR Voice will come together to talk about the impacts of immersive tech in the sector in an exclusive VRX webinar.

vr webinar,vr healthcare,virtual reality healthcare,vrx

On July 17, experts in VR & AR from Penn Medicine, Biogen, Stanford University and VR Voice will come together to talk about the impacts of immersive tech in the sector in an exclusive VRX webinar.

The use of virtual and augmented reality (XR) in the healthcare and pharmaceutical industries has been a major area of growth over the last 12 months. However, there are still many regulatory challenges to overcome, and plenty of questions still to be answered.

Concerns around privacy and safety are very much at the top of regulators’ minds, with issues around liability and ownership of data sources of great contention. As the technologies become more accessible and widespread, a comprehensive regulatory framework is required to ensure patients’ interests are maintained, while allowing the use of the technologies to thrive.

With over 90% of healthcare currently experimenting with XR, AI and blockchain, the potential of advanced technologies to transform patient care is clear to see; from training surgeons to enhancing physiotherapy and pain management to the treatment of phobias. In conjunction with this, pharmaceutical companies are seeing huge benefits in using the technologies for improved drug visualization, worker training and customer engagement, too.

To truly benefit from the potential of XR, however, healthcare providers, research institutions, companies, tech providers and regulators must all assess where the market is and isn’t ready for growth, how to overcome concerns around privacy and safety and how to truly measure the impact VR & AR are having across the sector.

Join VRX on Wednesday July 17 at 9 a.m. PT / 12 p.m. ET as we bring experts together from Penn Medicine, Biogen, Stanford University and VR Voice to explore VR & AR for Healthcare & Pharma — Overcome Challenges, Find Opportunities and Drive ROI.

Register for this free webinar today for exclusive insights into:

What are the best applications and which XR technologies are best suited?

Benefits and challenges: How is healthcare being transformed? Where is it not ready?

• Looking at market growth for VR & AR tech in the sector and gaps to exploit

How is ROI measured and who’s gaining the most benefit from XR technologies?

Those who cannot join live will be sent the recordings once the webinar has run. For more information, please contact Kathryn Bloxham on the details below.

Kathryn Bloxham

VR Intelligence / VRX

T: +44 (0)207 375 7567

E: [email protected]

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
George Van Antwerp, MBA
Edmondo Robinson, MD
Craig Newman
© 2024 MJH Life Sciences

All rights reserved.